Aromatase inhibitors: An overview for surgeons

被引：6

作者：

Bickenbach, Kai A. ^{[1
]}

Jaskowiak, Nora ^{[1
]}

机构：

[1] Univ Chicago, Dept Surg, Chicago, IL 60637 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2006年 / 203卷 / 03期

关键词：

D O I：

10.1016/j.jamcollsurg.2006.05.291

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：376 / 389

页数：14

共 60 条

[1]

Allred DC, 2002, BREAST CANCER RES TR, V76, pS36

[2]

Baum M, 2002, LANCET, V359, P2131

[3]

Baum M, 2003, Cancer, V98, P1802

[4]

Beatson GT., 1896, LANCET, V148, P104, DOI DOI 10.1016/S0140-6736(01)72307-0

[5] Fadrozole versus megestrol acetate: A double-blind randomised trial in advanced breast cancer [J].

Bezwoda, WR ;

Gudgeon, A ;

Falkson, G ;

Jordaan, JP ;

Goedhals, L .

ONCOLOGY, 1998, 55 (05) :416-420

[6] Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: Results of an Italian cooperative study [J].

Boccardo, F ;

Rubagotti, A ;

Amoroso, D ;

Mesiti, M ;

Romeo, D ;

Caroti, C ;

Farris, A ;

Cruciani, G ;

Villa, E ;

Schieppati, G ;

Mustacchi, G .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) :4209-4215

[7] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial [J].

Boccardo, F ;

Rubagotti, A ;

Puntoni, M ;

Guglielmini, P ;

Amoroso, D ;

Fini, A ;

Paladini, G ;

Mesiti, M ;

Romeo, D ;

Rinaldini, M ;

Scali, S ;

Porpiglia, M ;

Benedetto, C ;

Restuccia, N ;

Buzzi, F ;

Franchi, R ;

Massidda, B ;

Distante, V ;

Amadori, D ;

Sismondi, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5138-5147

[8] AROMATASE-ACTIVITY AND ESTRADIOL IN HUMAN BREAST-CANCER - ITS RELATIONSHIP TO ESTRADIOL AND EPIDERMAL GROWTH-FACTOR RECEPTORS AND TO TUMOR-NODE-METASTASIS STAGING [J].

BOLUFER, P ;

RICART, E ;

LLUCH, A ;

VAZQUEZ, C ;

RODRIGUEZ, A ;

RUIZ, A ;

LLOPIS, F ;

GARCIACONDE, J ;

ROMERO, R .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :438-446

[9] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].

Bonneterre, J ;

Thürlimann, B ;

Robertson, JFR ;

Krzakowski, M ;

Mauriac, L ;

Koralewski, P ;

Vergote, I ;

Webster, A ;

Steinberg, M ;

von Euler, M .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757

[10]

Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO

← 1 2 3 4 5 6 →